Bart Schade

Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then.